Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Open-Label, Multicenter Study Evaluating The Safety And Efficacy of Axicabtagene Ciloleucel Concomitant With Prophylactic Steroids In Subjects With Relapsed Or Refractory Large B-Cell Lymphoma In The Outpatient Setting

NCT05459571 is registered in ClinicalTrials.gov with Kite, A Gilead Company as lead sponsor.

NCT NCT05459571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Open-Label, Multicenter Study Evaluating The Safety And Efficacy of Axicabtagene Ciloleucel Concomitant With Prophylactic Steroids In Subjects With Relapsed Or Refractory Large B-Cell Lymphoma In The Outpatient Setting
Lead sponsor
Kite, A Gilead Company
Phase
Phase 2
Overall status
Completed
Start date
August 9, 2022
Completion date
November 24, 2025
Enrollment
35 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed or refractory large b-cell lymphoma